We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Noninvasive Glucose Monitor Cleared by FDA

By HospiMedica staff writers
Posted on 03 Apr 2001
A novel monitoring system that provides automatic, noninvasive glucose readings up to three times an hour has been cleared by the U.S. More...
Food and Drug Administration (FDA).

The system, called GlucoWatch Biographer, consists of two integrated parts, the Biographer and the AutoSensor. The Biographer is worn like a watch on the wrist. The AutoSensor snaps into the back of the Biographer and adheres to the skin. The AutoSensor collects the glucose sample by using an extremely low electric current to pull glucose through the skin. The glucose is transformed into an electric signal that is converted into a glucose reading. The Biographer calculates, displays, and stores glucose readings.

The GlucoWatch measures and displays glucose levels automatically, as often as every 20 minutes, for up to 12 hours. It also creates an electronic diary, storing up to 4,000 values that can be reviewed at the touch of a button, helping to detect trends and track patterns in glucose levels. In addition, users can set personal glucose alert levels so that an alarm sounds if readings are too high or too low, or if readings decline rapidly. GlucoWatch is the product of Cygnus, Inc. (Redwood City, CA, USA; www.cygn.com).
Cygnus has received the CE Mark to market the system in Europe. The company notes that the system is not designed to replace the fingerstick testing method but rather to be used together with that method to provide more complete, ongoing information about glucose.

"Cygnus is continuing efforts toward establishing capabilities to distribute and support the GlucoWatch Biographer in select worldwide markets, including the United States and Europe,” said John C. Hodgman, chairman and CEO of Cygnus.





Related Links:
Cygnus
GlucoWatch

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Gas Analyzer
GE SAM
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.